Clinical observation on the treatment of chronic pelvic inflammatory disease by adding and reducingBranchia fuling decoction
枝茯苓汤加减治疗慢性盆腔炎临床观察

摘要

目的 分析桂枝茯苓汤加减疗法用于慢性盆腔炎的价值。方法 对2021年1月-2022年3月本科接诊慢性盆腔炎病人（n=96）进行随机分组，试验和对照组各48人，前者采取桂枝茯苓汤加减法，后者行常规治疗。对比复发率等指标。结果 关于总有效率，试验组的数据是97.92%，和对照组的83.33%相比更高（P＜0.05）。关于IL-2和hs-CRP，疗程结束之时：试验组的数据分别是（5.97±0.94）ng/L、（4.05±0.91）mg/L，和对照组（3.99±0.65）ng/L、（7.92±1.03）mg/L相比更好（P＜0.05）。关于复发率，试验组的数据是2.08%，和对照组的18.75%相比更低（P＜0.05）。关于sf-36评分，疗程结束之时：试验组的数据是（90.36±2.57）分，和对照组（83.41±3.52）分相比更高（P＜0.05）。结论 慢性盆腔炎用桂枝茯苓汤加减法，复发率更低，疗效更好，血清炎性因子改善更加明显，生活质量提升更为迅速。

Abstract

Objective To analyze the value of guizhi Tuckahoe Decoction in treating chronic pelvic inflammatory disease.
Methods From January 2021 to March 2022, 96 patients with chronic pelvic inflammatory disease (N =96) were randomly divided into two groups: 48 patients in the experiment and 48 in the control group. The former received guizhifu decoction plus subtraction, and the latter received conventional treatment. Compare relapse rate and other indicators.
Results The total effective rate of the experimental group was 97.92%, which was higher than that of the control group (83.33%) (P < 0.05). As for IL-2 and HS-CRP, at the end of the treatment course, the data of the experimental group were (5.97±0.94) ng/L and (4.05±0.91) mg/L, respectively, which were better than those of the control group (3.99±0.65) ng/L and (7.92±1.03) mg/L (P < 0.05). The recurrence rate of the experimental group was 2.08%, which was lower than that of the control group (18.75%) (P < 0.05). As for THE SF-36 score, at the end of treatment, the score of the experimental group was (90.36±2.57), which was higher than that of the control group (83.41±3.52) (P < 0.05).
Conclusion   Guizhiporia cocos decoction can reduce the recurrence rate, improve the serum inflammatory factors and improve the quality of life more rapidly.